Tag: CBT > Synthetically Derived THC: Page 2

Utah

Utah Department of Agriculture and Food Issues Statement on Synthetic and Derivative Cannabinoids

The department is clarifying its stance on synthetic and derivative cannabinoids found in the state’s hemp and medical cannabis products.

November 21, 2022

Legislation and Regulation

CCIA Calls for Oversight on Delta-8 THC, Other Cannabinoids

The California cannabis trade group authored a white paper warning about the dangers of a national hemp-derived intoxicating cannabinoid market.

October 20, 2022

Legislation and Regulation

What Oregon’s Ban on Synthetic Cannabinoids Means for the Industry

Regulators have banned the sale of all artificially derived cannabinoids outside the state’s regulated cannabis market. Industry stakeholders explain why they think this is problematic.

August 16, 2022

Legislation and Regulation

Confusion in Kansas Continues: Douglas County District Attorney Says Businesses Selling Delta-8 THC Will Be Prosecuted

The Douglas County District Attorney’s Office has released two letters addressing the legality of delta-8 THC in Kansas, citing it as a “Schedule 1 controlled substance.”

June 16, 2022

Oregon

Oregon to Ban Sale of Synthetic Cannabinoids Starting July 1

Next year, starting in July 2023, the state will allow retailers licensed by the Oregon Liquor and Cannabis Commission to sell synthetic cannabinoids—as long as they are approved by the FDA.

June 13, 2022

Legislation and Regulation

Virginia Lawmakers Reject Governor’s Cannabis Misdemeanor Proposal in Veto Session

The attempt by Gov. Youngkin was to establish new penalties for those in possession of more than 2 ounces of cannabis.

April 28, 2022